• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者报告的肺癌症状影响(PRISM-LC)。

Patient-reported impact of symptoms in lung cancer (PRISM-LC).

作者信息

Varma Anika, Weinstein Jennifer, Seabury Jamison, Rosero Spencer, Zizzi Christine, Dilek Nuran, Heatwole John, Baumgart Megan, Mulford Deborah, Maggiore Ronald, Conrow Lainie, King Jennifer C, Wiens Jacinta, Heatwole Chad

机构信息

Center for Health + Technology, University of Rochester, CU, Rochester, NY, USA.

Department of Neurology, University of Rochester, Rochester, NY, USA.

出版信息

Transl Lung Cancer Res. 2023 Jul 31;12(7):1391-1413. doi: 10.21037/tlcr-22-831. Epub 2023 Jul 11.

DOI:10.21037/tlcr-22-831
PMID:37577309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10413040/
Abstract

BACKGROUND

Individuals with lung cancer (LC) face a variety of symptoms that significantly impact their lives. We use extensive patient input to determine the relative importance and prevalence of these symptoms and identify which demographic features are associated with a higher level of disease burden.

METHODS

We performed semi-structured qualitative interviews with participants with LC to identify potentially important symptoms. We then conducted a cross-sectional study, in which participants rated the relative importance of 162 individual symptoms covering 14 symptomatic themes. Participant responses were analyzed by age, sex, disability status, disease duration, LC stage, type of treatment received, and smoking history, among other categories.

RESULTS

Our cross-sectional study had 139 participants with LC. The most prevalent symptomatic themes reported by this population were fatigue (85.5%), impaired sleep and daytime sleepiness (73.5%), and emotional issues (73.0%). The symptomatic themes that had the greatest average impact (on a scale of 0 to 4, with 4 being the most impactful) were social role dissatisfaction (1.67), inability to do activities (1.64), and fatigue (1.60). Disability status had the strongest association with symptomatic theme prevalence. LC stage (stage IV), receipt of therapy, and smoking experience were also associated with higher frequency of symptomatic themes.

CONCLUSIONS

Individuals with LC face diverse and disease-specific symptoms that affect their daily lives. Patient insight on the prevalence and relative importance of these symptoms is invaluable to advance meaningful therapeutic interventions.

摘要

背景

肺癌患者面临多种严重影响其生活的症状。我们通过广泛收集患者意见来确定这些症状的相对重要性和普遍性,并确定哪些人口统计学特征与更高水平的疾病负担相关。

方法

我们对肺癌患者进行了半结构化定性访谈,以确定潜在的重要症状。然后我们开展了一项横断面研究,让参与者对涵盖14个症状主题的162种个体症状的相对重要性进行评分。参与者的回答按年龄、性别、残疾状况、疾病持续时间、肺癌分期、接受的治疗类型和吸烟史等类别进行分析。

结果

我们的横断面研究有139名肺癌患者。该人群报告的最普遍的症状主题是疲劳(85.5%)、睡眠障碍和日间嗜睡(73.5%)以及情绪问题(73.0%)。平均影响最大的症状主题(评分范围为0至4,4表示影响最大)是社会角色不满(1.67)、无法进行活动(1.64)和疲劳(1.60)。残疾状况与症状主题的普遍性关联最强。肺癌分期(IV期)、接受治疗和吸烟经历也与症状主题的较高发生率相关。

结论

肺癌患者面临多种特定于疾病的症状,这些症状会影响他们的日常生活。患者对这些症状的普遍性和相对重要性的见解对于推进有意义的治疗干预非常宝贵。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4a/10413040/34291df918ed/tlcr-12-07-1391-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4a/10413040/5cb589d05562/tlcr-12-07-1391-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4a/10413040/34291df918ed/tlcr-12-07-1391-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4a/10413040/5cb589d05562/tlcr-12-07-1391-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4a/10413040/34291df918ed/tlcr-12-07-1391-f2.jpg

相似文献

1
Patient-reported impact of symptoms in lung cancer (PRISM-LC).患者报告的肺癌症状影响(PRISM-LC)。
Transl Lung Cancer Res. 2023 Jul 31;12(7):1391-1413. doi: 10.21037/tlcr-22-831. Epub 2023 Jul 11.
2
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM).纤维肌痛患者报告的症状影响(PRISM-FM)。
J Rheumatol. 2024 Jun 1;51(6):628-636. doi: 10.3899/jrheum.2023-0698.
3
Patient-Reported Impact of Symptoms in Crohn's Disease.患者报告的克罗恩病症状影响。
Am J Gastroenterol. 2022 Dec 1;117(12):2033-2045. doi: 10.14309/ajg.0000000000001954. Epub 2022 Aug 22.
4
Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional study.患者报告的肌萎缩侧索硬化症症状影响(PRISM-ALS):一项全国性横断面研究。
EClinicalMedicine. 2022 Dec 13;55:101768. doi: 10.1016/j.eclinm.2022.101768. eCollection 2023 Jan.
5
Patient-reported impact of symptoms in Huntington disease: PRISM-HD.亨廷顿病患者报告的症状影响:PRISM-HD。
Neurology. 2020 May 12;94(19):e2045-e2053. doi: 10.1212/WNL.0000000000008906. Epub 2020 Mar 19.
6
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).2型强直性肌营养不良患者报告的症状影响(PRISM-2)
Neurology. 2015 Dec 15;85(24):2136-46. doi: 10.1212/WNL.0000000000002225. Epub 2015 Nov 18.
7
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).面肩肱型肌营养不良症患者报告的症状(PRISM-FSHD)。
Neurology. 2019 Sep 17;93(12):e1180-e1192. doi: 10.1212/WNL.0000000000008123. Epub 2019 Aug 13.
8
Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD).肾上腺脑白质营养不良患者报告的症状影响(PRISM-ALD)。
Orphanet J Rare Dis. 2024 Mar 19;19(1):127. doi: 10.1186/s13023-024-03129-6.
9
Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).脊髓性肌萎缩症患者症状影响报告(PRISM-SMA)。
Neurology. 2018 Sep 25;91(13):e1206-e1214. doi: 10.1212/WNL.0000000000006241. Epub 2018 Aug 24.
10
Patient-Reported Impact of Symptoms in Friedreich Ataxia.弗里德里希共济失调患者症状的报告影响。
Neurology. 2023 Feb 21;100(8):e808-e821. doi: 10.1212/WNL.0000000000201598. Epub 2022 Nov 28.

引用本文的文献

1
Influence of symptom burden on social alienation in lung cancer patients receiving chemotherapy: the chain mediating effect of perceived social support and positive psychological capital.症状负担对接受化疗的肺癌患者社会疏离感的影响:领悟社会支持与积极心理资本的链式中介作用
BMC Psychol. 2025 Feb 4;13(1):99. doi: 10.1186/s40359-025-02403-x.
2
Patient- and Caregiver-Reported Impact of Symptoms in Alzheimer Disease, Mild Cognitive Impairment, and Dementia.患者及照料者报告的阿尔茨海默病、轻度认知障碍和痴呆症状的影响
Neurol Clin Pract. 2025 Feb;15(1):e200418. doi: 10.1212/CPJ.0000000000200418. Epub 2024 Dec 6.

本文引用的文献

1
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.针对具有致癌驱动分子改变的肺癌患者的靶向治疗。
J Clin Oncol. 2022 Feb 20;40(6):611-625. doi: 10.1200/JCO.21.01626. Epub 2022 Jan 5.
2
Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors.利用癌症登记处评估免疫检查点抑制剂的患者报告结局
Cancers (Basel). 2020 Dec 31;13(1):103. doi: 10.3390/cancers13010103.
3
Patient-reported impact of symptoms in Huntington disease: PRISM-HD.亨廷顿病患者报告的症状影响:PRISM-HD。
Neurology. 2020 May 12;94(19):e2045-e2053. doi: 10.1212/WNL.0000000000008906. Epub 2020 Mar 19.
4
Biases in health expectancies due to educational differences in survey participation of older Europeans: It's worth weighting for.由于较年长欧洲人在调查参与方面的教育差异导致的预期寿命偏差:值得加权处理。
Eur J Health Econ. 2020 Jun;21(4):573-605. doi: 10.1007/s10198-019-01152-0. Epub 2020 Jan 27.
5
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.非小细胞肺癌靶向治疗的新兴治疗领域。
Signal Transduct Target Ther. 2019 Dec 17;4:61. doi: 10.1038/s41392-019-0099-9. eCollection 2019.
6
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).面肩肱型肌营养不良症患者报告的症状(PRISM-FSHD)。
Neurology. 2019 Sep 17;93(12):e1180-e1192. doi: 10.1212/WNL.0000000000008123. Epub 2019 Aug 13.
7
Risk of lung cancer in relation to various metrics of smoking history: a case-control study in Montreal.吸烟史各项指标与肺癌风险的关系:蒙特利尔的病例对照研究。
BMC Cancer. 2018 Dec 19;18(1):1275. doi: 10.1186/s12885-018-5144-5.
8
Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).脊髓性肌萎缩症患者症状影响报告(PRISM-SMA)。
Neurology. 2018 Sep 25;91(13):e1206-e1214. doi: 10.1212/WNL.0000000000006241. Epub 2018 Aug 24.
9
Quality of life for non-small cell lung cancer patients in the age of immunotherapy.免疫治疗时代非小细胞肺癌患者的生活质量
Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S149-S152. doi: 10.21037/tlcr.2018.03.10.
10
Patient-identified impact of symptoms in spinal and bulbar muscular atrophy.患者确认的脊髓和延髓性肌萎缩症状的影响
Muscle Nerve. 2018 Jan;57(1):40-44. doi: 10.1002/mus.25957. Epub 2017 Sep 25.